Literature DB >> 18212577

Proteomics in neuropathic pain research.

Ellen Niederberger1, Gerd Geisslinger.   

Abstract

Neuropathic pain is often caused by nerve injury or dysfunction in the peripheral and central nervous system and is frequently associated with allodynia and hyperalgesia. The underlying molecular mechanisms of neuropathic pain are largely unknown, and therefore, pharmacologic treatment is insufficient in many cases. To elucidate translational and posttranslational modifications in the nervous system that arise after nerve injury, a number of proteomic studies have been performed using different animal neuropathy models. The results of these proteomic approaches are summarized in this review to provide a better overview of proteins that are involved into the pathogenesis of nerve injury and neuropathic pain. This might allow a better understanding of the pathophysiologic signaling pathways in this impairment, facilitate the discovery of specific biomarkers, and thus promote the development of novel pain therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212577     DOI: 10.1097/01.anes.0000299838.13368.6e

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  20 in total

1.  Standardized Profiling of The Membrane-Enriched Proteome of Mouse Dorsal Root Ganglia (DRG) Provides Novel Insights Into Chronic Pain.

Authors:  Tom Rouwette; Julia Sondermann; Luca Avenali; David Gomez-Varela; Manuela Schmidt
Journal:  Mol Cell Proteomics       Date:  2016-04-21       Impact factor: 5.911

2.  PI3K/Akt Pathway is Required for Spinal Central Sensitization in Neuropathic Pain.

Authors:  Wei Liu; Yanling Lv; Facheng Ren
Journal:  Cell Mol Neurobiol       Date:  2017-08-28       Impact factor: 5.046

3.  2020 Foresight: Envisioning Therapeutic Innovations for Pain.

Authors:  May Hamza; Raymond A Dionne
Journal:  Drug Discov Today Ther Strateg       Date:  2009

4.  Proteomic analysis of differential proteins related to the neuropathic pain and neuroprotection in the dorsal root ganglion following its chronic compression in rats.

Authors:  Yang Zhang; Yong-Hui Wang; Xu-Hua Zhang; Hong-You Ge; Lars Arendt-Nielsen; Jian-Min Shao; Shou-Wei Yue
Journal:  Exp Brain Res       Date:  2008-05-21       Impact factor: 1.972

5.  Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancer.

Authors:  Nada Lukkahatai; Sajni Patel; Marjan Gucek; Chao-Pin Hsiao; Leorey N Saligan
Journal:  J Pain Symptom Manage       Date:  2013-07-31       Impact factor: 3.612

6.  Proteome characterization of small extracellular vesicles from spared nerve injury model of neuropathic pain.

Authors:  Renee Jean-Toussaint; Yuzhen Tian; Amrita Datta Chaudhuri; Norman J Haughey; Ahmet Sacan; Seena K Ajit
Journal:  J Proteomics       Date:  2019-10-24       Impact factor: 4.044

7.  Nerve injury evoked loss of latexin expression in spinal cord neurons contributes to the development of neuropathic pain.

Authors:  Hilmar Nils Kühlein; Irmgard Tegeder; Christine Möser; Hee-Young Lim; Annett Häussler; Katharina Spieth; Ingo Jennes; Rolf Marschalek; Tobias Beckhaus; Michael Karas; Markus Fauth; Corina Ehnert; Gerd Geisslinger; Ellen Niederberger
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  Multivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls - a hypothesis-generating pilot study.

Authors:  Emmanuel Bäckryd; Bijar Ghafouri; Anders K Carlsson; Patrik Olausson; Björn Gerdle
Journal:  J Pain Res       Date:  2015-07-01       Impact factor: 3.133

9.  Pain in the Blood? Envisioning Mechanism-Based Diagnoses and Biomarkers in Clinical Pain Medicine.

Authors:  Emmanuel Bäckryd
Journal:  Diagnostics (Basel)       Date:  2015-03-17

10.  Identification of proteins from interstitium of trapezius muscle in women with chronic myalgia using microdialysis in combination with proteomics.

Authors:  Patrik Olausson; Björn Gerdle; Nazdar Ghafouri; Britt Larsson; Bijar Ghafouri
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.